DENV circulation by immune status in the PDCS and PDHS combined, Managua, 2004–2024.

DENV circulation by immune status in the PDCS and PDHS combined, Managua, 2004–2024.

<p>Circulating serotypes and immune status in dengue cases in the studies in Managua are represented. The hospital study was not run in 2020 and 2021. P, primary; S, secondary.</p>

Saved in:

Bibliographic Details
Main Author:	Federico Narvaez (197554) (author)
Other Authors:	Carlos Montenegro (2887661) (author), Jose G. Juarez (5937815) (author), José Victor Zambrana (5324849) (author), Karla Gonzalez (404055) (author), Elsa Videa (365296) (author), Sonia Arguello (5324852) (author), Fanny Barrios (20543004) (author), Sergio Ojeda (2847896) (author), Miguel Plazaola (5324855) (author), Nery Sanchez (2847887) (author), Daniel Camprubí-Ferrer (11711184) (author), Guillermina Kuan (179743) (author), Gabriela Paz Bailey (20543007) (author), Eva Harris (27355) (author), Angel Balmaseda (109173) (author)
Published:	2025
Subjects:	Medicine Microbiology Molecular Biology Biotechnology Immunology Cancer Science Policy Infectious Diseases Virology Mathematical Sciences not elsewhere classified low platelet count findings demonstrate differences pediatric clinical studies 17 years old similar disease severity pediatric dengue hospital severe disease compared whereas denv3 caused nicaragua </ p severe disease hospital stay denv3 caused dengue severity clinical manifestations 19 years severity classification dengue vaccine dengue cases xlink "> virological methods pleural effusion increased odds immune status higher proportion greatest percentage denv3 cases denv infection critical need balanced effectiveness 833 participants 644 cases 559 corresponded 21 %) 2009 classification
Tags:	Add Tag No Tags, Be the first to tag this record!